Skip to content
Screener

Medline, Inc. MDLN Proceeds From Issuance Of Other Long Term Debt

Proceeds From Issuance Of Other Long Term Debt at other companies

Canadian Pacific Kansas City logo
Canadian Pacific Kansas CityCP
$775.5M
Brink's, Inc. logo
Brink's, Inc.BCO
$5M+22.0%
Regal Rexnord logo
Regal RexnordRRX
$850M
Essential Utilities logo
Essential UtilitiesWTRG
$510.1M-28.0%
ESAB logo
ESABESAB
$773.05M+8,812%
Medline, Inc. logo
Medline, Inc.MDLN
$1.89B-52.5%

Other financials

Income statement

See full
Revenue$7.7B+11.6%
Gross profit$2.2B+16.3%
Operating income$395.0M-38.5%
Net income$139.0M-57.8%
EPS (diluted)$0.07

Balance sheet

See full
Cash & equivalents$2.3B+299%
Total debt$12.6B
Total equity$11.6B
Total assets$39.4B

Cash flow

See full
Operating cash flow$715.0M+263%
CapEx$111.0M+0.9%
Free cash flow$604.0M+594%

Valuation

See full
Market cap$29.66B-4.6%
Enterprise value$39.95B
P/E33.4×
P/S

Profitability

See full
Gross margin27.5%+1.1pp
Operating margin8.7%+1.7pp
Net margin4.7%+1.8pp
FCF margin5.2%-0.6pp

Returns & leverage

See full
Return on equity7.8%
Debt / equity1.1×
Current ratio4.3×

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt.

The source filing: Medline, Inc.’s 10-K, filed February 25, 2026.

Filed
Feb 25, 2026, 4:51 PM EST
Fiscal year
FY2025
Accession
0002046386-26-000009
(in millions)Year ended / December 31, 2025Year ended / December 31, 2024Year ended / December 31, 2023
Proceeds from issuance of Class A common stock in initial public offering, net of underwriting discounts and commissions7,048
Purchase of Class A common stock and redemptions of Common Units from Pre-IPO owners(1,970)
Payment for offering costs(36)
Proceeds from long-term borrowings7,56915,932
Repayment for long-term borrowings(11,661)(15,995)(77)
Repayments under lines of credit(179)(166)
Proceeds from lines of credit179166
Payment for debt issuance cost(12)

Item 8 - Financial Statements and Supplementary Data

FAQ

What is Medline, Inc.'s proceeds from issuance of other long term debt?
Medline, Inc. (MDLN) reported proceeds from issuance of other long term debt of $1.89B in Q4 2025.
How has Medline, Inc.'s proceeds from issuance of other long term debt changed year-over-year?
Medline, Inc.'s proceeds from issuance of other long term debt decreased by 52.5% year-over-year, from $3.98B to $1.89B.
What does proceeds from issuance of other long term debt mean?
Represents the cash inflow from the issuance of long-term debt instruments, such as bonds or term loans. This reflects the company's ability to access credit markets to fund long-term investments or refinance existing obligations.

Ask your AI about Medline, Inc.'s proceeds from issuance of other long term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude